Articles
| Open Access | EVALUATING LACTOBACILLUS CASEI PROBIOTIC EFFICACY IN MILD TO MODERATE ULCERATIVE COLITIS: A PLACEBO-CONTROLLED INVESTIGATION
Ali Asad Azmi , Department Of Internal Medicine, Imam Reza Hospital, Mashhad University Of Medical Sciences, Mashhad, IranAbstract
Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by recurrent episodes of inflammation and ulceration of the colon's mucosal lining. Probiotics, such as Lactobacillus casei, have emerged as potential therapeutic agents for UC due to their anti-inflammatory and immunomodulatory properties. This placebo-controlled study aimed to assess the impact of Lactobacillus casei probiotic supplementation on patients with mild to moderate UC. A randomized, double-blind trial was conducted involving UC patients who received either Lactobacillus casei probiotics or a placebo for a specified duration. Disease activity, clinical symptoms, quality of life, and inflammatory markers were evaluated. The study's findings provide valuable insights into the efficacy of Lactobacillus casei probiotics as a complementary therapy for UC management.
Keywords
Ulcerative colitis, Lactobacillus casei, Probiotics
References
Katz S. Update in medical therapy of ulcerative colitis: Newer concepts and therapies. J Clin Gastroenterol 2005; 39:557-69.
Zigra PI, Maipa VE, Alamanos YP. Probiotics and remission of ulcerative colitis: A systematic review. Neth J Med 2007; 65:411-8.
Shanahan F. Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics. Gastroenterology 2001; 120:622-35.
Onderdonk AB, Bronson R, Cisneros R. Comparison of Bacteroides vulgatus strains in the enhancement of experimental ulcerative colitis. Infect Immun 1987; 55:835-6.
Ohkusa T, Okayasu I, Ogihara T, Morita K, Ogawa M, Sato N. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut 2003; 52:79-83.
Binder V. Epidemiology of IBD during the twentieth century: An integrated view. Best Pract Res Clin Gastroenterol 2004; 18:463-79.
Chandran P, Satthaporn S, Robins A, Eremin O. Inflammatory bowel disease: Dysfunction of GALT and gut bacterial flora (I). Surgeon 2003; 1:63-75.
Poxton IR, Brown R, Sawyerr A, Ferguson A. Mucosa-associated bacterial flora of the human colon. J Med Microbiol 1997; 46:85-91.
Ruseler‑van Embden JG, Schouten WR, van Lieshout LM. Pouchitis: Result of microbial imbalance? Gut 1994; 35:658-64.
Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66:365-78.